Cargando…
The abundance of RNPS1, a protein component of the exon junction complex, can determine the variability in efficiency of the Nonsense Mediated Decay pathway
Nonsense-mediated mRNA decay (NMD) is a molecular pathway of mRNA surveillance that ensures rapid degradation of mRNAs containing premature translation termination codons (PTCs) in eukaryotes. NMD has been shown to also regulate normal gene expression and thus emerged as one of the key post-transcri...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1935013/ https://www.ncbi.nlm.nih.gov/pubmed/17586820 http://dx.doi.org/10.1093/nar/gkm461 |
_version_ | 1782134364930310144 |
---|---|
author | Viegas, Marcelo H. Gehring, Niels H. Breit, Stephen Hentze, Matthias W. Kulozik, Andreas E. |
author_facet | Viegas, Marcelo H. Gehring, Niels H. Breit, Stephen Hentze, Matthias W. Kulozik, Andreas E. |
author_sort | Viegas, Marcelo H. |
collection | PubMed |
description | Nonsense-mediated mRNA decay (NMD) is a molecular pathway of mRNA surveillance that ensures rapid degradation of mRNAs containing premature translation termination codons (PTCs) in eukaryotes. NMD has been shown to also regulate normal gene expression and thus emerged as one of the key post-transcriptional mechanisms of gene regulation. Recently, NMD efficiency has been shown to vary between cell types and individuals thus implicating NMD as a modulator of genetic disease severity. We have now specifically analysed the molecular mechanism of variable NMD efficiency and first established an assay system for the quantification of NMD efficiency, which is based on carefully validated cellular NMD target transcripts. In a HeLa cell model system, NMD efficiency is shown to be remarkably variable and to represent a stable characteristic of different strains. In one of these strains, low NMD efficiency is shown to be functionally related to the reduced abundance of the exon junction component RNPS1. Furthermore, restoration of functional RNPS1 expression, but not of NMD-inactive mutant proteins, also restores efficient NMD in this model. We conclude that cellular concentrations of RNPS1 can modify NMD efficiency and propose that cell type specific co-factor availability represents a novel principle that controls NMD. |
format | Text |
id | pubmed-1935013 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-19350132007-08-07 The abundance of RNPS1, a protein component of the exon junction complex, can determine the variability in efficiency of the Nonsense Mediated Decay pathway Viegas, Marcelo H. Gehring, Niels H. Breit, Stephen Hentze, Matthias W. Kulozik, Andreas E. Nucleic Acids Res RNA Nonsense-mediated mRNA decay (NMD) is a molecular pathway of mRNA surveillance that ensures rapid degradation of mRNAs containing premature translation termination codons (PTCs) in eukaryotes. NMD has been shown to also regulate normal gene expression and thus emerged as one of the key post-transcriptional mechanisms of gene regulation. Recently, NMD efficiency has been shown to vary between cell types and individuals thus implicating NMD as a modulator of genetic disease severity. We have now specifically analysed the molecular mechanism of variable NMD efficiency and first established an assay system for the quantification of NMD efficiency, which is based on carefully validated cellular NMD target transcripts. In a HeLa cell model system, NMD efficiency is shown to be remarkably variable and to represent a stable characteristic of different strains. In one of these strains, low NMD efficiency is shown to be functionally related to the reduced abundance of the exon junction component RNPS1. Furthermore, restoration of functional RNPS1 expression, but not of NMD-inactive mutant proteins, also restores efficient NMD in this model. We conclude that cellular concentrations of RNPS1 can modify NMD efficiency and propose that cell type specific co-factor availability represents a novel principle that controls NMD. Oxford University Press 2007-07 2007-06-22 /pmc/articles/PMC1935013/ /pubmed/17586820 http://dx.doi.org/10.1093/nar/gkm461 Text en © 2007 The Author(s) http://creativecommons.org/licenses/by-nc/2.0/uk/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | RNA Viegas, Marcelo H. Gehring, Niels H. Breit, Stephen Hentze, Matthias W. Kulozik, Andreas E. The abundance of RNPS1, a protein component of the exon junction complex, can determine the variability in efficiency of the Nonsense Mediated Decay pathway |
title | The abundance of RNPS1, a protein component of the exon junction complex, can determine the variability in efficiency of the Nonsense Mediated Decay pathway |
title_full | The abundance of RNPS1, a protein component of the exon junction complex, can determine the variability in efficiency of the Nonsense Mediated Decay pathway |
title_fullStr | The abundance of RNPS1, a protein component of the exon junction complex, can determine the variability in efficiency of the Nonsense Mediated Decay pathway |
title_full_unstemmed | The abundance of RNPS1, a protein component of the exon junction complex, can determine the variability in efficiency of the Nonsense Mediated Decay pathway |
title_short | The abundance of RNPS1, a protein component of the exon junction complex, can determine the variability in efficiency of the Nonsense Mediated Decay pathway |
title_sort | abundance of rnps1, a protein component of the exon junction complex, can determine the variability in efficiency of the nonsense mediated decay pathway |
topic | RNA |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1935013/ https://www.ncbi.nlm.nih.gov/pubmed/17586820 http://dx.doi.org/10.1093/nar/gkm461 |
work_keys_str_mv | AT viegasmarceloh theabundanceofrnps1aproteincomponentoftheexonjunctioncomplexcandeterminethevariabilityinefficiencyofthenonsensemediateddecaypathway AT gehringnielsh theabundanceofrnps1aproteincomponentoftheexonjunctioncomplexcandeterminethevariabilityinefficiencyofthenonsensemediateddecaypathway AT breitstephen theabundanceofrnps1aproteincomponentoftheexonjunctioncomplexcandeterminethevariabilityinefficiencyofthenonsensemediateddecaypathway AT hentzematthiasw theabundanceofrnps1aproteincomponentoftheexonjunctioncomplexcandeterminethevariabilityinefficiencyofthenonsensemediateddecaypathway AT kulozikandrease theabundanceofrnps1aproteincomponentoftheexonjunctioncomplexcandeterminethevariabilityinefficiencyofthenonsensemediateddecaypathway AT viegasmarceloh abundanceofrnps1aproteincomponentoftheexonjunctioncomplexcandeterminethevariabilityinefficiencyofthenonsensemediateddecaypathway AT gehringnielsh abundanceofrnps1aproteincomponentoftheexonjunctioncomplexcandeterminethevariabilityinefficiencyofthenonsensemediateddecaypathway AT breitstephen abundanceofrnps1aproteincomponentoftheexonjunctioncomplexcandeterminethevariabilityinefficiencyofthenonsensemediateddecaypathway AT hentzematthiasw abundanceofrnps1aproteincomponentoftheexonjunctioncomplexcandeterminethevariabilityinefficiencyofthenonsensemediateddecaypathway AT kulozikandrease abundanceofrnps1aproteincomponentoftheexonjunctioncomplexcandeterminethevariabilityinefficiencyofthenonsensemediateddecaypathway |